Surveillance of invasive pneumococcal disease in 30 EU countries: towards a European system ?

Publié le 1 Janvier 2010
Mis à jour le 10 septembre 2019

In this era of new pneumococcal conjugate vaccines (PCV), we described and compared surveillance of invasive pneumococcal disease (IPD) and PCV policies in 30 European countries to provide guidance for Europe-wide surveillance. We confirmed the heterogeneity of surveillance systems and case definitions across countries but identified elements common to all countries, such as the availability of serotyping and the surveillance of pneumococcal meningitis. PCV impact was monitored in 11/15 countries using it. We propose steps for the monitoring of incidence rates and serotype distribution at EU level, to assess the need to introduce PCV and monitor its impact once introduced. (R.A.)

Auteur : Hanquet G, Perrocheau A, Kissling E, Levy Bruhl D, Tarrago D, Stuart J, Stefanoff P, Heuberger S, Kriz B, Vergison A, de Greeff SC, Amato Gauci A, Pastore Celentano L
Vaccine, 2010, vol. 28, n°. 23, p. 3920-8